|
|
 |
|
Viewing report
|
|
|
|
Medicated Skin Care in Mexico
Euromonitor International, April 2012, Pages: 49
Diabetes rates are soaring in Mexico due to unhealthy diets and obesity, reaching more than nine million people in 2011 according to the Mexican Diabetes Federation. Due to the wide range of side effects caused by diabetes, the epidemic is impacting many categories in the field of health. One of these side effects is the appearance of skin fungus, driving demand for antifungal products. Some companies, such as local player Genomma Lab, are capitalising on this epidemic, launching several new...
The Medicated Skin Care in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
|
|
|
|
